Tu1120 LEMBOREXANT IS MORE EFFECTIVE IN PATIENTS WITH GASTROESOPHAGEAL REFLUX DISEASE WITH A LONGER UPRIGHT ACID EXPOSURE TIME.

Gastroenterology(2024)

引用 0|浏览0
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要